| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |